As Galectin-3 stabilizes cell surface cytokine receptors and inhibits T-cell apoptosis it may hinder inflammation resolution across the cardiovascular and renal systems, thus skewing toward maladaptive repair and chronicity following AKI (144). The gene discussed is LGALS3; the disease is acute kidney injury.